Literature DB >> 32937048

Tolerance in the Age of Immunotherapy.

Jeffrey A Bluestone1, Mark Anderson1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32937048      PMCID： PMC7534289          DOI： 10.1056/NEJMra1911109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  78 in total

1.  DELINEATION OF THE THYMIC AND BURSAL LYMPHOID SYSTEMS IN THE CHICKEN.

Authors:  M D COOPER; R D PETERSON; R A GOOD
Journal:  Nature       Date:  1965-01-09       Impact factor: 49.962

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 3.  The multiple pathways to autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Roberto Baccala
Journal:  Nat Immunol       Date:  2017-06-20       Impact factor: 25.606

4.  An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

Authors:  Kevan C Herold; Brian N Bundy; S Alice Long; Jeffrey A Bluestone; Linda A DiMeglio; Matthew J Dufort; Stephen E Gitelman; Peter A Gottlieb; Jeffrey P Krischer; Peter S Linsley; Jennifer B Marks; Wayne Moore; Antoinette Moran; Henry Rodriguez; William E Russell; Desmond Schatz; Jay S Skyler; Eva Tsalikian; Diane K Wherrett; Anette-Gabriele Ziegler; Carla J Greenbaum
Journal:  N Engl J Med       Date:  2019-06-09       Impact factor: 91.245

5.  Interleukin-2 and regulatory T cells in graft-versus-host disease.

Authors:  John Koreth; Ken-ichi Matsuoka; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Edwin P Alyea; Philippe Armand; Corey Cutler; Vincent T Ho; Nathaniel S Treister; Don C Bienfang; Sashank Prasad; Dmitrios Tzachanis; Robin M Joyce; David E Avigan; Joseph H Antin; Jerome Ritz; Robert J Soiffer
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

6.  Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.

Authors:  Stephan Busque; John D Scandling; Robert Lowsky; Judith Shizuru; Kent Jensen; Jeffrey Waters; Hsin-Hsu Wu; Kevin Sheehan; Asha Shori; Okmi Choi; Thomas Pham; Marcelo A Fernandez Vina; Richard Hoppe; John Tamaresis; Philip Lavori; Edgar G Engleman; Everett Meyer; Samuel Strober
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

Review 7.  B-Cell Therapies in Multiple Sclerosis.

Authors:  Joseph J Sabatino; Scott S Zamvil; Stephen L Hauser
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

Review 8.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

9.  Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.

Authors:  Stephen E Gitelman; Peter A Gottlieb; Eric I Felner; Steven M Willi; Lynda K Fisher; Antoinette Moran; Michael Gottschalk; Wayne V Moore; Ashley Pinckney; Lynette Keyes-Elstein; Kristina M Harris; Sai Kanaparthi; Deborah Phippard; Linna Ding; Jeffrey A Bluestone; Mario R Ehlers
Journal:  Diabetologia       Date:  2016-04-06       Impact factor: 10.122

Review 10.  Engineered T Regulatory Type 1 Cells for Clinical Application.

Authors:  Silvia Gregori; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561
View more
  14 in total

Review 1.  Regulation of activated T cell survival in rheumatic autoimmune diseases.

Authors:  Florencia Rosetti; Iris K Madera-Salcedo; Noé Rodríguez-Rodríguez; José C Crispín
Journal:  Nat Rev Rheumatol       Date:  2022-01-24       Impact factor: 32.286

Review 2.  Type 1 diabetes mellitus: much progress, many opportunities.

Authors:  Alvin C Powers
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 3.  Emerging concepts in PD-1 checkpoint biology.

Authors:  Kristen E Pauken; James A Torchia; Apoorvi Chaudhri; Arlene H Sharpe; Gordon J Freeman
Journal:  Semin Immunol       Date:  2021-05-15       Impact factor: 11.130

Review 4.  Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.

Authors:  Alan H Baik; Olalekan O Oluwole; Douglas B Johnson; Nina Shah; Joe-Elie Salem; Katy K Tsai; Javid J Moslehi
Journal:  Circ Res       Date:  2021-05-03       Impact factor: 23.213

Review 5.  Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy.

Authors:  Elena Goleva; Taras Lyubchenko; Lukas Kraehenbuehl; Mario E Lacouture; Donald Y M Leung; Jeffrey A Kern
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-11       Impact factor: 6.248

Review 6.  HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance.

Authors:  Baimei Zhuang; Jin Shang; Yuanqing Yao
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

Review 7.  Immune-mediated inflammatory disease therapeutics: past, present and future.

Authors:  Iain B McInnes; Ellen M Gravallese
Journal:  Nat Rev Immunol       Date:  2021-09-13       Impact factor: 53.106

8.  Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant.

Authors:  Sudipta Tripathi; Paloma L Martin-Moreno; George Kavalam; Brittany L Schreiber; Ana Maria Waaga-Gasser; Anil Chandraker
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

Review 9.  Control of inflammation using non-invasive neuromodulation: past, present and promise.

Authors:  Aisling Tynan; Michael Brines; Sangeeta S Chavan
Journal:  Int Immunol       Date:  2022-01-22       Impact factor: 4.823

Review 10.  Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis.

Authors:  María José Docampo; Andreas Lutterotti; Mireia Sospedra; Roland Martin
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.